Found: 28
Select item for more details and to access through your institution.
Mifepristone Paternalism at the FDA.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, n. 3, p. 554, doi. 10.1017/jme.2023.98
- By:
- Publication type:
- Article
The CRISPR Patent Ruling and Implications for Medicine.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 6, p. 461, doi. 10.1001/jama.2022.24986
- By:
- Publication type:
- Article
Mifepristone Paternalism at the FDA.
- Published in:
- Traditio: Studies in Ancient & Medieval History Thought & Religion, 2023, v. 78, p. 554, doi. 10.1017/jme.2023.98
- By:
- Publication type:
- Article
STUMBLING OVER TRIPS: THE INTERNATIONAL INTELLECTUAL PROPERTY WAIVER PETITION AND THE U.S. EXECUTIVE.
- Published in:
- Michigan State International Law Review, 2022, v. 30, n. 2, p. 249
- By:
- Publication type:
- Article
INSULIN FEDERALISM.
- Published in:
- Journal of Science & Technology Law, 2021, v. 27, n. 1, p. 118
- By:
- Publication type:
- Article
FDA Publicity and Enforcement in the COVID-19 Era.
- Published in:
- Washburn Law Journal, 2020, v. 60, n. 1, p. 77
- By:
- Publication type:
- Article
COVID-IP: staring down the Bayh–Dole Act with 2020 vision.
- Published in:
- Journal of Law & the Biosciences, 2020, v. 7, n. 1, p. 1, doi. 10.1093/jlb/lsaa073
- By:
- Publication type:
- Article
Regulating Nanomedicine at the Food and Drug Administration.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 4, p. 347, doi. 10.1001/amajethics.2019.347
- By:
- Publication type:
- Article
Public Health Preparedness & Response: An Exercise in Administrative Law.
- Published in:
- DePaul Journal of Health Care Law, 2018, v. 20, n. 2, p. 1
- By:
- Publication type:
- Article
Regulatory Silence at the FDA.
- Published in:
- Minnesota Law Review, 2018, v. 102, n. 6, p. 2383
- By:
- Publication type:
- Article
21<sup>st</sup> Century Citizen Pharma: The FDA & Patient-Focused Product Development.
- Published in:
- 2018
- By:
- Publication type:
- journal article
EXPLORING PRECISION FDA, AN ONLINE PLATFORM FOR CROWDSOURCING GENOMICS.
- Published in:
- Jurimetrics: The Journal of Law, Science & Technology, 2018, v. 58, n. 3, p. 267
- By:
- Publication type:
- Article
CULTIVATING INNOVATION IN PRECISION MEDICINE THROUGH REGULATORY FLEXIBILITY AT THE FDA.
- Published in:
- New York University Journal of Law & Liberty, 2017, v. 11, n. 2, p. 672
- By:
- Publication type:
- Article
The Legal and Regulatory Status of Biosimilars: How Product Naming and State Substitution Laws May Impact the United States Healthcare System.
- Published in:
- American Journal of Law & Medicine, 2015, v. 41, n. 1, p. 49, doi. 10.1177/0098858815591509
- By:
- Publication type:
- Article
REMS AS A COMPETITIVE TACTIC: IS BIG PHARMA HIJACKING DRUG ACCESS AND PATIENT SAFETY?
- Published in:
- Houston Journal of Health Law & Policy, 2015, v. 15, n. 1, p. 43
- By:
- Publication type:
- Article
Electronic Cigarettes: Smoke-Free Laws, Sale Restrictions, and the Public Health.
- Published in:
- American Journal of Public Health, 2014, v. 104, n. 6, p. e17, doi. 10.2105/AJPH.2014.301890
- By:
- Publication type:
- Article
Synthetic Biology: Does Re-Writing Nature Require Re-Writing Regulation?
- Published in:
- Penn State Law Review, 2012, v. 117, n. 1, p. 53
- By:
- Publication type:
- Article
REASSESSING SAFETY FOR NANOTECHNOLOGY COMBINATION PRODUCTS: WHAT DO BIOSIMILARS ADD TO REGULATORY CHALLENGES FOR THE FDA?
- Published in:
- St. Louis University Law Journal, 2012, v. 56, n. 2, p. 465
- By:
- Publication type:
- Article
Recommendations for oversight of nanobiotechnology: dynamic oversight for complex and convergent technology.
- Published in:
- Journal of Nanoparticle Research, 2011, v. 13, n. 4, p. 1345, doi. 10.1007/s11051-011-0233-2
- By:
- Publication type:
- Article
THE DEVIL IS IN THE DETAILS: HEALTH-CARE REFORM, BIOSIMILARS, AND IMPLEMENTATION CHALLENGES FOR THE FOOD AND DRUG ADMINISTRATION.
- Published in:
- Jurimetrics: The Journal of Law, Science & Technology, 2011, v. 51, n. 3, p. 279
- By:
- Publication type:
- Article
Follow-On Biologics: Implementation Challenges and Opportunities.
- Published in:
- Seton Hall Law Review, 2011, v. 41, n. 2, p. 501
- By:
- Publication type:
- Article
INTRODUCTION.
- Published in:
- Journal of Law, Medicine & Ethics, 2009, v. 37, n. 4, p. 543, doi. 10.1111/j.1748-720X.2009.00430.x
- By:
- Publication type:
- Article
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology.
- Published in:
- Journal of Law, Medicine & Ethics, 2009, v. 37, n. 4, p. 598, doi. 10.1111/j.1748-720X.2009.00434.x
- By:
- Publication type:
- Article
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences.
- Published in:
- Journal of Law, Medicine & Ethics, 2009, v. 37, n. 4, p. 688, doi. 10.1111/j.1748-720X.2009.00441.x
- By:
- Publication type:
- Article
An Integrated Approach to Oversight Assessment for Emerging Technologies.
- Published in:
- Risk Analysis: An International Journal, 2008, v. 28, n. 5, p. 1197, doi. 10.1111/j.1539-6924.2008.01086.x
- By:
- Publication type:
- Article
Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations.
- Published in:
- Journal of Law, Medicine & Ethics, 2008, v. 36, n. 2, p. 219, doi. 10.1111/j.1748-720X.2008.00266.x
- By:
- Publication type:
- Article
Decoding the research exemption.
- Published in:
- 2006
- By:
- Publication type:
- research
Call for Biohistory Guidelines.
- Published in:
- 2005
- By:
- Publication type:
- Letter